Joseph Byrne - Apr 19, 2021 Form 3 Insider Report for CEN BIOTECH INC (CENBF)

Role
President, Director
Signature
/s/ Joseph Byrne
Stock symbol
CENBF
Transactions as of
Apr 19, 2021
Transactions value $
$0
Form type
3
Date filed
6/3/2021, 08:41 AM
Previous filing
May 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CENBF Common Stock 1.36M Apr 19, 2021 Direct F1
holding CENBF Common Stock 164K Apr 19, 2021 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CENBF Common Stock Apr 19, 2021 Common Stock 76.1K $1.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Joseph Byrne (the "Reporting Person") was appointed to his positions with CEN Biotech, Inc. (the "Issuer") on April 19, 2021 and owned 1,362,894 shares of the Issuer's common stock at such date.
F2 The Reporting Person also beneficially owns a convertible note with 76,123 shares issuable upon conversion of same.